Summary This article provides a high-yield overview of frequently tested yet often "missed" topics in respiratory pathology, designed to complement a broader st
Summary This article provides a high-yield overview of frequently tested yet often "missed" topics in respiratory pathology, designed to complement a broader study of the respiratory system. It covers eleven distinct areas, ranging from immunologically mediated lung diseases like hypersensitivity pneumonitis and pulmonary eosinophilia, to smoking-related interstitial diseases, and lung involvement in systemic conditions like collagen vascular disease and Wegener granulomatosis. The content also delves into specific causes of pulmonary disease such as drug/radiation-induced injury, idiopathic pulmonary hemosiderosis, and various nonthrombotic pulmonary emboli. Finally, it details the pathology of neuroendocrine tumors like carcinoid, the aggressive malignant mesothelioma, and key chronic fungal pneumonias (histoplasmosis, coccidioidomycosis, blastomycosis), concluding with a critical section on pneumonia in immunocompromised hosts, highlighting specific pathogens and their diagnostic features. The focus is on key distinctions, diagnostic markers, characteristic morphologies, and management principles, emphasizing points often tested in multiple-choice questions and clinical scenarios. It serves as a crucial resource for solidifying understanding of less common but important respiratory pathologies. Key Points - Hypersensitivity Pneumonitis : An immunologically mediated inflammatory lung disease affecting alveoli, often occupational, involving Type III and Type IV hypersensitivity. Key distinction from asthma is alveolar (not bronchial) injury. - Pulmonary Eosinophilia : A group of conditions characterized by eosinophil infiltration in the lung, often immunologic. Löffler Syndrome is transient and benign; Acute Eosinophilic Pneumonia responds well to corticosteroids. - Smoking-Related Interstitial Diseases : Desquamative Interstitial Pneumonia (DIP) and Respiratory Bronchiolitis (RB-ILD) are both caused by smoking, characterized by "smoker's macrophages," and generally have an excellent prognosis with smoking cessation. - Collagen Vascular Disease (Lung Involvement) : Many systemic autoimmune diseases can cause various pulmonary patterns (NSIP, UIP, vasculitis, pleural involvement), and lung involvement typically indicates a poor prognosis. Clinical context is crucial for diagnosis, especially with UIP patterns. - Drug- and Radiation-Induced Pulmonary Disease : Bleomycin and Amiodarone are known to cause pneumonitis and fibrosis. Radiation pneumonitis occurs 1-6 months post-therapy with infiltrates corresponding to the radiation field. - Idiopathic Pulmonary Hemosiderosis : A rare disease with pulmonary manifestations similar to Goodpasture syndrome (hemoptysis, anemia, infiltrates) but without renal disease or anti-GBM antibodies. - Wegener Granulomatosis : Characterized by necrotizing vasculitis and granulomatous inflammation in the lung, often with upper respiratory and renal involvement. Diagnostically linked to c-ANCA (PR3-ANCA) positivity. - Carcinoid Tumors of the Lung : Neuroendocrine tumors arising from Kulchitsky cells, less aggressive than SCLC. Classified as typical (low-grade, better prognosis) or atypical (intermediate-grade). Positive for neuroendocrine markers like chromogranin. - Malignant Mesothelioma : A primary pleural malignancy strongly linked to asbestos exposure, with a long latency period. Distinguished from adenocarcinoma by IHC markers (Calretinin+, CEA-, TTF-1-). Grim prognosis. - Nonthrombotic Pulmonary Emboli : Includes Fat Embolism (trauma, long bone fractures), Air Embolism (iatrogenic), Amniotic Fluid Embolism (catastrophic obstetric emergency), and Talc Embolism (IV drug abuse leading to granulomas and pulmonary hypertension). - Chronic Fungal Pneumonias : Histoplasmosis (Ohio/Mississippi valleys, yeast in macrophages), Coccidioidomycosis (SW USA, spherules with endospores), and Blastomycosis (N. America, broad-based budding yeast) are major causes of chronic granulomatous pneumonia, each with distinct geography and pathology. - Pneumonia in Immunocompromised Host : Key pathogens depend on the immune defect. PCP (Pneumocystis jiroveci) is common in AIDS (CD4 2/3 of cases; usually peribronchiolar location - Advanced chronic: diffuse interstitial fibrosis Clinical Features: - Acute form: fever, cough, dyspnea, constitutional symptoms 4–8 hours after exposure - Temporal relationship = key to diagnosis - Remove antigen → complete resolution within days - Chronic form: insidious onset — cough, dyspnea, malaise, weight loss - Failure to remove antigen → irreversible chronic interstitial pulmonary disease HIGH YIELD: If antigen NOT removed → irreversible fibrosis. This is the critical management point examiners test. 2. PULMONARY EOSINOPHILIA MUST KNOWS - Group of conditions characterized by infiltration and activation of eosinophils in the lung - Elevated alveolar IL-5 drives eosinophil activation - Generally immunologic in origin; etiology often unknown 5 Categories: 1. Acute Eosinophilic Pneumonia - Rapid onset: fever, dyspnea, hypoxia, diffuse pulmonary infiltrates on CXR - BAL fluid: 25% eosinophils - Prompt response to corticosteroids (dramatic improvement) 2. Simple Pulmonary Eosinophilia (Löffler Syndrome) - Transient pulmonary lesions + blood eosinophilia + benign clinical course - Alveolar septa thickened by eosinophils + occasional giant cells - Often self-limiting 3. Tropical Eosinophilia - Caused by infection with microfilariae and helminthic parasites - Endemic areas 4. Secondary Eosinophilia - Associated with: asthma , drug allergies, certain vasculitides 5. Idiopathic Chronic Eosinophilic Pneumonia - Aggregates of lymphocytes + eosinophils in septal walls + alveolar spaces - Characteristically in periphery of lung fields - Symptoms: high fever, night sweats, dyspnea - Diagnosis of exclusion (all other causes of pulmonary eosinophilia must be ruled out) MCQ TRAP: Löffler syndrome = simple eosinophilia + benign course + transient. Chronic eosinophilic pneumonia = peripheral distribution + high fever + diagnosis of exclusion. 3. SMOKING-RELATED INTERSTITIAL DISEASES MUST KNOWS Two related conditions — both from smoking, both restrictive: Desquamative Interstitial Pneumonia (DIP) - Most striking histologic feature: accumulation of large numbers of macrophages with dusty-brown pigment ("smoker's macrophages") in air spaces - Alveolar septa thickened by sparse lymphocytic infiltrate - Interstitial fibrosis: mild when present - Pulmonary function: mild restrictive abnormality - Excellent prognosis — good response to: - Steroid therapy - Smoking cessation The name "desquamative" is a misnomer — early pathologists thought the cells were desquamated epithelial cells; they are actually macrophages . Respiratory Bronchiolitis (RB-ILD) - Common histologic lesion in smokers - Pigmented intraluminal macrophages (same as DIP) but in "bronchiolocentric" distribution (first- and second-order respiratory bronchioles) - Mild peribronchiolar fibrosis - Presentation: gradual onset dyspnea + dry cough - Symptoms recede with smoking cessation DIP vs RB-ILD comparison: Feature DIP RB-ILD :-------------------- :---------------------- :---------------------- Macrophage distribution Diffuse air spaces Bronchiolocentric Fibrosis Mild Mild peribronchiolar Treatment response Steroids + smoking cessation Smoking cessation Prognosis Excellent Good 4. COLLAGEN VASCULAR DISEASE — LUNG INVOLVEMENT MUST KNOWS - Many collagen vascular diseases have pulmonary manifestations: - Systemic lupus erythematosus (SLE) - Rheumatoid arthritis (RA) - Systemic sclerosis (scleroderma) - Dermatomyositis-polymyositis Histologic patterns seen (multiple possible in same patient): - NSIP pattern (most common in systemic sclerosis) - UIP pattern (similar to IPF) - Vascular sclerosis - Organizing pneumonia (COP pattern) - Bronchiolitis (small airway disease ± fibrosis) - Pleural involvement: pleuritis, pleural nodules, pleural effusion Prognosis: - Pulmonary involv